# RXWell to Decrease Post-Operative Opioid Use in Total Knee or Hip Arthroplasty

> **NCT05658796** · NA · RECRUITING · sponsor: **University of Pittsburgh** · enrollment: 150 (estimated)

## Conditions studied

- Mood Disorders
- Anxiety
- Depressive Symptoms
- Depression
- Anxiety Disorders
- Anxiety Depression

## Interventions

- **BEHAVIORAL:** +RxWell
- **BEHAVIORAL:** -RxWell

## Key facts

- **NCT ID:** NCT05658796
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-27
- **Primary completion:** 2026-12-01
- **Final completion:** 2026-12-30
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-11-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05658796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05658796, "RXWell to Decrease Post-Operative Opioid Use in Total Knee or Hip Arthroplasty". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05658796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*